<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Kawasaki disease: Epidemiology and etiology</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Kawasaki disease: Epidemiology and etiology</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Kawasaki disease: Epidemiology and etiology</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert Sundel, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marisa Klein-Gitelman, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth TePas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 26, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Kawasaki disease (KD, previously called mucocutaneous lymph node syndrome) is one of the most common vasculitides of childhood, particularly in East Asia. It is typically a self-limited condition, with fever and other acute inflammatory manifestations lasting for an average of 12 days if not treated. The underlying etiology is unknown.</p><p>KD can cause a variety of cardiovascular complications, including coronary artery aneurysms, cardiomyopathy with depressed myocardial contractility and heart failure, myocardial infarction, arrhythmias, and peripheral arterial occlusion. These complications may cause significant morbidity and mortality, particularly in children who are inadequately treated. The frequency of aneurysm development and mortality has dramatically decreased as a result of intravenous <a class="drug drug_pediatric" data-topicid="83878" href="/z/d/drug information/83878.html" rel="external">immune globulin</a> therapy. Early diagnosis is critical to achieve the optimal treatment result.</p><p>The epidemiology and etiology of KD are reviewed here. The clinical features, diagnosis, treatment, and cardiac sequelae are presented separately. Incomplete KD is also discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6417.html" rel="external">"Kawasaki disease: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6423.html" rel="external">"Kawasaki disease: Initial treatment and prognosis"</a> and  <a class="medical medical_review" href="/z/d/html/5772.html" rel="external">"Cardiovascular sequelae of Kawasaki disease: Clinical features and evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/15689.html" rel="external">"Incomplete (atypical) Kawasaki disease"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>KD is second only to immunoglobulin A (IgA) vasculitis (Henoch-Schönlein purpura) as the most common vasculitis of childhood [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Geographic variation</span><span class="headingEndMark"> — </span>The incidence of KD is greatest in children who live in East Asia or are of Asian ancestry living in other parts of the world [<a href="#rid2">2-4</a>]. The incidence in underdeveloped countries is largely unknown, and ascertainment is likely to be incomplete. KD is particularly difficult to diagnose in areas where measles is still prevalent since the presentation is similar [<a href="#rid5">5,6</a>]. Many nations around the world have demonstrated an increase in the number of children diagnosed with KD since the early to mid-2000s. It is not clear, however, whether this represents an actual increase in the incidence of the disease, increased awareness of the condition, or a greater tendency to classify children with incomplete clinical features as having KD.</p><p>The following studies illustrate the geographic and ethnic variation in the incidence of KD:</p><p class="bulletIndent1"><span class="glyph">●</span>Japan – KD is a reportable disease in Japan, and almost 250,000 cases of KD have been registered there since its initial description by Tomisaku Kawasaki in 1967 [<a href="#rid7">7,8</a>]. The incidence among children younger than five years of age was approximately 215 per 100,000 per year in 2007 and 2008, with the incidence in boys aged zero to four years reaching as high as 240 per 100,000 [<a href="#rid8">8</a>]. The highest incidence was among children aged 6 to 11 months. Thus, approximately 1 in 100 Japanese children develops KD by the age of five years, making KD a very common illness in Japan.</p><p></p><p class="bulletIndent1">Although epidemics of KD were observed in Japan in 1979, 1982, and 1986, there has not been an epidemic since that time. However, incidence rates now exceed the rates observed during the three previous epidemics [<a href="#rid8">8</a>]. In Japan, KD is most prevalent in the winter, with a smaller peak evident in summer [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Taiwan and China – Data from the Taiwan National Health Insurance Database indicate that the incidence of KD among children younger than five years was 69 per 100,000 per year between 2003 and 2006 [<a href="#rid9">9</a>]. A hospital-based survey of KD in all 45 hospitals in Beijing reported an increase in the incidence in children younger than five years of age from 41 per 100,000 in 2000 to 51 per 100,000 in 2004 [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>United States – Studies of hospital discharge records by the United States Centers for Disease Control (CDC) estimated an overall annual incidence of 20 per 100,000 children younger than five years in the United States [<a href="#rid11">11</a>]. Annual incidence was highest among Asians and Pacific Islanders (30 per 100,000), intermediate among non-Hispanic African Americans (17 per 100,000) and Hispanics (16 per 100,000), and lowest among Caucasians (12 per 100,000) [<a href="#rid11">11</a>]. A winter-spring predominance of cases is characteristic, and the peak incidence of illness is at less than one year of age [<a href="#rid11">11</a>]. In contrast to Japan, surveillance in the United States is passive, and many cases may be missed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>England – In an analysis of national admissions data in England, the annual incidence of KD for children under five years of age averaged 8 per 100,000 from 1998 to 2003 [<a href="#rid12">12</a>]. The incidences were higher for children of Chinese ethnicity and those who lived in areas of greatest urban density and with the greatest degree of poverty.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Israel – A retrospective study using the Israel National Hospital Discharge Register indicated an increase in KD incidence in Israel from 5 per 100,000 children under five years of age from 1996 to 1999 to 7 per 100,000 in 2000 to 2004 [<a href="#rid13">13</a>]. For male infants under one year of age, the KD incidence rate doubled between 1996 to 1998 and 1999 to 2009.</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Other risk factors</span><span class="headingEndMark"> — </span>Boys are affected as much as 50 percent more commonly than girls [<a href="#rid3">3,9,10,14,15</a>]. Eighty to 90 percent of cases occur in children younger than five years [<a href="#rid9">9,16</a>], although KD is relatively uncommon among children younger than six months (approximately 10 percent of KD hospitalizations in the United States) [<a href="#rid11">11</a>]. Occurrence beyond late childhood is rare [<a href="#rid16">16,17</a>], although older children can develop KD and may experience delays in diagnosis and higher rates of coronary artery disease [<a href="#rid18">18,19</a>]. Fewer than 100 cases of classic KD in adults had been reported in the literature at the time of a 2010 case series and review [<a href="#rid20">20</a>].</p><p>The epidemiology of the illness is illustrated by an analysis of data from the Pediatric Health Information System (PHIS) that identified 4811 patients who were treated in 27 hospitals in the United States between 2001 and 2006 [<a href="#rid3">3</a>]. The median age at first admission was 3.4 years (range 1 month to 21.3 years), and 60 percent of the patients were between one and four years of age. Sixty percent of patients were male. Patients of Asian ancestry were overrepresented in the KD group compared with the overall patient group contained within the PHIS data set (6.9 versus 1.6 percent).</p><p>In Japan, there is a reported 10-fold increased risk of KD for children with an affected sibling and a twofold increased risk for those with a previously affected parent [<a href="#rid21">21,22</a>]. In North America, there are case reports of families with multiple affected members, but data are insufficient to determine whether there is an increased familial risk for developing KD [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H6"><span class="h1">POSSIBLE ETIOLOGIC FACTORS</span><span class="headingEndMark"> — </span>The etiology of KD remains unknown. A variety of theories have been proposed based upon pathologic, epidemiologic, and demographic data [<a href="#rid24">24</a>]. Infection by one or more agents that usually cause an asymptomatic or nonvasculitic condition in most children, but which results in KD in genetically predisposed individuals, fits the epidemiologic data well [<a href="#rid25">25</a>]. Various case series over many years have reported localized outbreaks of KD, each associated with a different bacterial or viral pathogen such as parvovirus B19 [<a href="#rid26">26</a>], <em>Propionibacterium</em> [<a href="#rid27">27</a>], human bocavirus [<a href="#rid28">28</a>], and numerous others.</p><p>The major debate concerns whether KD is caused by a single, heretofore unidentified agent or an immunologic response to a variety of triggers. This point remains unresolved, although the possibility of a unique KD infection seems less likely with each negative serologic, genetic, and immunologic study or case series [<a href="#rid25">25</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Immunologic response</span><span class="headingEndMark"> — </span>KD is a systemic, inflammatory illness that particularly affects medium-sized arteries, especially the coronary arteries. Pathologic studies indicate that multiple organs and tissues are involved [<a href="#rid29">29</a>], but long-term sequelae appear to occur only in the arteries. Blood vessel damage appears to result from inflammatory cell infiltration into vascular tissues. The stimulus for this infiltration is unknown, but it is most profound in the coronary arteries and can involve destruction of luminal endothelial cells, elastic lamina, and medial smooth muscle cells in severe cases. The destruction of elastin and collagen fibers and loss of structural integrity of the arterial wall lead to dilatation and aneurysm formation. Inflammatory cells infiltrating the coronary arteries may include neutrophils, T cells (particularly CD8 T cells), eosinophils, plasma cells (particularly IgA producing), and macrophages. Macrophages are not prominent participants in any other type of vasculitis [<a href="#rid30">30</a>].</p><p>A neutrophilic infiltrate is observed in the arterial wall in KD fatalities that occur within the first two weeks after fever onset and may represent an innate immune response [<a href="#rid31">31</a>]. A study of gene expression patterns in acute KD peripheral blood using DNA microarrays reflects the predominance of neutrophils early in the course of KD [<a href="#rid32">32</a>]. Expression of genes associated with neutrophils and inflammatory processes, including adrenomedullin, grancalcin, and granulin, was high during the acute phase of illness. Levels of these transcripts tended to decrease over time, while gene expression in CD8 T cells and natural killer (NK) cells increased as the illness evolved. CD8 T cells were prevalent in the arterial wall in fatalities that occurred after two weeks in another study, consistent with the development of an acquired immune response [<a href="#rid33">33</a>]. Gene expression in the peripheral blood from individual patients tended to be more consistent than were transcript levels in different subjects on the same day of illness. This suggests the possibility that DNA polymorphisms affected individuals' gene expression.</p><p>Plasma cells producing oligoclonal IgA antibodies are found in the arteries and respiratory tract of children with KD [<a href="#rid34">34</a>]. A synthetic monoclonal antibody derived from prevalent IgA sequences in the KD arterial wall identified intracytoplasmic inclusion bodies consistent with aggregates of proteins and nucleic acids in 85 percent of KD cases but not in infant control tissues [<a href="#rid35">35,36</a>]. Immune complexes are sometimes detected in the peripheral blood in KD, but they are not observed to form deposits in affected tissues and do not appear to correlate with the development of coronary artery disease [<a href="#rid37">37,38</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Infectious etiology</span><span class="headingEndMark"> — </span>Many epidemiologic data suggest that KD is caused or triggered by a transmissible agent or agents. Support for this theory is derived from the following similarities between KD and other pediatric infectious conditions [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>KD is characterized by a febrile exanthem with lymphadenitis and mucositis. These are features similar to those of contagious diseases, such as adenovirus infection, measles, and scarlet fever.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is a seasonal increase in the winter and summer [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The disease often occurs in epidemics [<a href="#rid39">39,40</a>], and a geographic wave-like spread of illness during epidemics has been noted [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Boys are more susceptible than girls. In general, the "set-point" of the immune system varies between sexes, leading to an overall higher incidence and morbidity due to infections in males (eg, meningitis [<a href="#rid41">41</a>], <em>Campylobacter</em> enteritis [<a href="#rid42">42</a>], etc) and a higher incidence of autoimmune diseases in females [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Siblings of children with KD in Japan are at increased risk for developing the disease, which usually occurs within one week of onset of the index case [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The disease is common among children younger than five years but rare in those younger than six months. The rarity in infants may be explained by transfer of passive immunity to the relatively common infectious trigger(s) by transplacentally acquired maternal antibodies.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is spatial and temporal clustering of cases [<a href="#rid44">44</a>].</p><p></p><p>The cause(s) of KD remain(s) unknown despite clinical and epidemiologic data suggesting a relationship to infections. In fact, a retrospective review of 129 consecutive patients diagnosed during a 24-month period from 1997 to 1998 at a single, tertiary-care hospital found that 33 percent of children with typical KD had at least one confirmed infection at KD diagnosis [<a href="#rid45">45</a>]. However, a wide variety of different bacterial and viral infections were identified. Similarly, screening of patients with "universal" prokaryotic and eukaryotic primers has not identified a single infectious agent as the cause. Thus, the significance of findings, such as the presence of aggregates of particles that share morphologic features with several RNA virus families in a small number of patients with KD, remains unclear [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H1911413826"><span class="h3">Multisystem inflammatory syndrome in children</span><span class="headingEndMark"> — </span>Coronavirus disease 2019 (COVID-19) is associated with hyperinflammatory syndromes [<a href="#rid47">47</a>]. Children may develop organ failure involving the gastrointestinal tract, heart, central nervous system, kidneys, and other systems. The severe inflammation, cytopenias, coagulopathy, and hyperferritinemia are similar to macrophage activation syndrome or toxic shock in some children. Others develop mucocutaneous symptoms like those in KD [<a href="#rid48">48</a>]. In a percentage of such cases, coronary artery dilatation, and even formation of giant coronary aneurysms, may develop. (See  <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis"</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Genetic factors</span><span class="headingEndMark"> — </span>Genetic factors appear to contribute to the pathogenesis of this disorder, as suggested by the increased frequency of the disease in Asian and Asian-American populations and among family members of an index case [<a href="#rid1">1,21,49-52</a>].</p><p>Variants or polymorphisms of the following genes are associated with an increased susceptibility to KD:</p><p class="bulletIndent1"><span class="glyph">●</span>Inositol 1,4,5-trisphosphate 3-kinase C (<em>ITPKC</em>) gene on chromosome 19q13.2 [<a href="#rid53">53,54</a>]. ITPKC acts as a negative regulator of T cell activation, which includes transcription of interleukin (IL) 2. The single nucleotide polymorphism (SNP) associated with KD susceptibility results in a weaker inhibitory effect upon T cell activation. Patients with this SNP may have a more vigorous T cell response during an inflammatory disease, such as KD, compared with those without this allelic change. However, this polymorphism is not common enough even in the Japanese population to explain the vast majority of cases of KD.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Angiopoietin 1 (<em>ANGPT1</em>) and vascular endothelial growth factor A (<em>VEGFA</em>) genes [<a href="#rid55">55-57</a>]. Expression of angiopoietin 1 is upregulated and VEGF is downregulated in patients with acute versus convalescent KD, suggesting disruption of vascular homeostasis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The genes encoding the chemokine receptor CCR5 and its major ligand CCL3L1 [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The adenosine triphosphate (ATP) binding cassette, subfamily C, member 4 (<em>ABCC4</em>) gene. ABCC4 is a cyclic nucleotide transporter involved in migration of dendritic cells and cellular efflux of prostaglandin [<a href="#rid59">59</a>].</p><p></p><p>Genome-wide association studies have revealed other potential susceptibility loci, including a functional polymorphism in the immunoglobulin G receptor gene (<em>FCGR2A</em>) [<a href="#rid60">60-64</a>]. In addition to being a putative susceptibility factor, ITPKC is associated with an increased risk of coronary artery aneurysms. Other genetic factors related to the development of coronary lesions in KD are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5772.html" rel="external">"Cardiovascular sequelae of Kawasaki disease: Clinical features and evaluation", section on 'Coronary artery abnormalities'</a>.)</p><p class="headingAnchor" id="H2915263301"><span class="h1">ENVIRONMENTAL FACTORS</span><span class="headingEndMark"> — </span>Environmental factors also have been proposed as the triggers of KD. Overlap between the cutaneous and acral manifestations of KD to those of acrodynia, a disease caused by mercury toxicity, led to proposals that mercury might play a causative role in KD [<a href="#rid65">65</a>]. Similarly, the frequent association between KD and atopy, particularly atopic dermatitis, has inspired a search for a common immune susceptibility [<a href="#rid66">66</a>]. This has led to various hypotheses involving dust mites, rug shampoo, and pollen release in the etiology of KD, although, once again, additional data accrued over time have not provided support to these theories. Analysis of seasonal variations in epidemics of KD suggested to one group that cases are linked to largescale wind currents from Central Asia, potentially carrying an airborne antigenic trigger in the troposphere [<a href="#rid67">67</a>].</p><p>Despite the plausibility of these and numerous other theories, it is difficult to understand how a single environmental factor could account for a ubiquitous disease such as KD that occurs at all times of the year and in virtually every country on Earth. Thus, like other pediatric vasculitides such as IgA vasculitis (Henoch-Schönlein purpura) [<a href="#rid68">68</a>], KD may occur in genetically susceptible individuals following exposure to any of a variety of infectious and/or environmental triggers [<a href="#rid69">69</a>].</p><p class="headingAnchor" id="H114633988"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/17130.html" rel="external">"Patient education: Kawasaki disease (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H12069016"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Kawasaki disease (KD) is one of the most common vasculitides of childhood. The incidence of KD is greatest in children who live in East Asia (eg, Japan, Korea, Taiwan) or are of Asian ancestry living in other parts of the world. Other risk factors include male sex, age between six months and five years, and family history of KD. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology and pathogenesis</strong> – The etiology of KD remains unknown, but several etiologic factors have been postulated: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Immunologic response</strong> – Inflammatory cell infiltration into KD vascular tissue leads to vascular damage, but the stimulus for this inflammatory infiltration has not been identified. (See <a class="local">'Immunologic response'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Infectious etiology</strong> – The similarities between KD and other pediatric infectious conditions suggest that KD is caused by a transmissible agent. However, no studies have convincingly identified a specific virus, bacterium or bacterial toxin, or other pathogen associated with KD. The etiology may be a previously unidentified infectious agent. An alternative theory to a specific inciting agent is that KD represents a final common pathway of immune-mediated vascular inflammation following a variety of inciting infections and/or environmental antigens. (See <a class="local">'Infectious etiology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Genetic factors</strong> – Genetic factors appear to contribute to the pathogenesis of this disorder, as suggested by the increased frequency of the disease in Asian and Asian-American populations and among family members of an index case. A number of gene polymorphisms are associated with an increased susceptibility to KD, and some of these variants are also associated with coronary artery lesions and aneurysm formation. (See <a class="local">'Genetic factors'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Younger DS. Epidemiology of the Vasculitides. Neurol Clin 2019; 37:201.</a></li><li><a class="nounderline abstract_t">Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003; 112:495.</a></li><li><a class="nounderline abstract_t">Son MB, Gauvreau K, Ma L, et al. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics 2009; 124:1.</a></li><li><a class="nounderline abstract_t">Wu MH, Lin MT, Chen HC, et al. Postnatal Risk of Acquiring Kawasaki Disease: A Nationwide Birth Cohort Database Study. J Pediatr 2017; 180:80.</a></li><li><a class="nounderline abstract_t">Davaalkham D, Nakamura Y, Baigalmaa D, et al. Kawasaki disease in Mongolia: results from 2 nationwide retrospective surveys, 1996-2008. J Epidemiol 2011; 21:293.</a></li><li><a class="nounderline abstract_t">Badoe EV, Neequaye J, Oliver-Commey JO, et al. Kawasaki disease in ghana: case reports from Korle Bu teaching hospital. Ghana Med J 2011; 45:38.</a></li><li><a class="nounderline abstract_t">Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 1967; 16:178.</a></li><li><a class="nounderline abstract_t">Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol 2010; 20:302.</a></li><li><a class="nounderline abstract_t">Huang WC, Huang LM, Chang IS, et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 2009; 123:e401.</a></li><li><a class="nounderline abstract_t">Du ZD, Zhao D, Du J, et al. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004. Pediatr Infect Dis J 2007; 26:449.</a></li><li><a class="nounderline abstract_t">Holman RC, Belay ED, Christensen KY, et al. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 2010; 29:483.</a></li><li><a class="nounderline abstract_t">Harnden A, Mayon-White R, Perera R, et al. Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens. Pediatr Infect Dis J 2009; 28:21.</a></li><li><a class="nounderline abstract_t">Bar-Meir M, Haklai Z, Dor M. Kawasaki disease in Israel. Pediatr Infect Dis J 2011; 30:589.</a></li><li><a class="nounderline abstract_t">Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 1998; 102:E65.</a></li><li><a class="nounderline abstract_t">Fischer TK, Holman RC, Yorita KL, et al. Kawasaki syndrome in Denmark. Pediatr Infect Dis J 2007; 26:411.</a></li><li><a class="nounderline abstract_t">Yanagawa H, Yashiro M, Nakamura Y, et al. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics 1995; 95:475.</a></li><li><a class="nounderline abstract_t">Tomiyama J, Hasegawa Y, Kumagai Y, et al. Acute febrile mucocutaneous lymph node syndrome (Kawasaki disease) in adults: case report and review of the literature. Jpn J Med 1991; 30:285.</a></li><li><a class="nounderline abstract_t">Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr 2000; 137:250.</a></li><li><a class="nounderline abstract_t">Cai Z, Zuo R, Liu Y. Characteristics of Kawasaki disease in older children. Clin Pediatr (Phila) 2011; 50:952.</a></li><li><a class="nounderline abstract_t">Gomard-Mennesson E, Landron C, Dauphin C, et al. Kawasaki disease in adults: report of 10 cases. Medicine (Baltimore) 2010; 89:149.</a></li><li><a class="nounderline abstract_t">Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr 2001; 90:40.</a></li><li><a class="nounderline abstract_t">Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease in parents and children. Acta Paediatr 2003; 92:694.</a></li><li><a class="nounderline abstract_t">Dergun M, Kao A, Hauger SB, et al. Familial occurrence of Kawasaki syndrome in North America. Arch Pediatr Adolesc Med 2005; 159:876.</a></li><li><a class="nounderline abstract_t">Takahashi K, Oharaseki T, Yokouchi Y. Pathogenesis of Kawasaki disease. Clin Exp Immunol 2011; 164 Suppl 1:20.</a></li><li><a class="nounderline abstract_t">Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis 2005; 9:185.</a></li><li><a class="nounderline abstract_t">Nigro G, Zerbini M, Krzysztofiak A, et al. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet 1994; 343:1260.</a></li><li><a class="nounderline abstract_t">Kato H, Fujimoto T, Inoue O, et al. Variant strain of Propionibacterium acnes: a clue to the aetiology of Kawasaki disease. Lancet 1983; 2:1383.</a></li><li><a class="nounderline abstract_t">Catalano-Pons C, Giraud C, Rozenberg F, et al. Detection of human bocavirus in children with Kawasaki disease. Clin Microbiol Infect 2007; 13:1220.</a></li><li><a class="nounderline abstract_t">Amano S, Hazama F, Kubagawa H, et al. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 1980; 30:681.</a></li><li><a class="nounderline abstract_t">Jennette JC, Falk RJ. The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol 2007; 25:S52.</a></li><li><a class="nounderline abstract_t">Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn 1991; 41:785.</a></li><li><a class="nounderline abstract_t">Popper SJ, Shimizu C, Shike H, et al. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol 2007; 8:R261.</a></li><li><a class="nounderline abstract_t">Brown TJ, Crawford SE, Cornwall ML, et al. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001; 184:940.</a></li><li><a class="nounderline abstract_t">Rowley AH, Shulman ST, Spike BT, et al. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001; 166:1334.</a></li><li><a class="nounderline abstract_t">Rowley AH, Baker SC, Shulman ST, et al. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis 2005; 192:1757.</a></li><li><a class="nounderline abstract_t">Rowley AH, Baker SC, Shulman ST, et al. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS One 2008; 3:e1582.</a></li><li><a class="nounderline abstract_t">Mason WH, Jordan SC, Sakai R, et al. Circulating immune complexes in Kawasaki syndrome. Pediatr Infect Dis 1985; 4:48.</a></li><li><a class="nounderline abstract_t">Rowley AH, Eckerley CA, Jäck HM, et al. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997; 159:5946.</a></li><li><a class="nounderline abstract_t">Burns JC, Cayan DR, Tong G, et al. Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology 2005; 16:220.</a></li><li><a class="nounderline abstract_t">Yanagawa H, Nakamura Y, Yashiro M, et al. A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. J Infect Dis 1988; 158:1296.</a></li><li><a class="nounderline abstract_t">de Jonge RC, van Furth AM, Wassenaar M, et al. Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies. BMC Infect Dis 2010; 10:232.</a></li><li><a class="nounderline abstract_t">Wang SC, Chang LY, Hsueh PR, et al. Campylobacter enteritis in children in northern Taiwan--a 7-year experience. J Microbiol Immunol Infect 2008; 41:408.</a></li><li><a class="nounderline abstract_t">Oliver JE, Silman AJ. Why are women predisposed to autoimmune rheumatic diseases? Arthritis Res Ther 2009; 11:252.</a></li><li><a class="nounderline abstract_t">Kao AS, Getis A, Brodine S, Burns JC. Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J 2008; 27:981.</a></li><li><a class="nounderline abstract_t">Benseler SM, McCrindle BW, Silverman ED, et al. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 2005; 116:e760.</a></li><li><a class="nounderline abstract_t">Rowley AH, Baker SC, Shulman ST, et al. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease. J Infect Dis 2011; 203:1021.</a></li><li><a class="nounderline abstract_t">Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395:1607.</a></li><li><a class="nounderline abstract_t">Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395:1771.</a></li><li><a class="nounderline abstract_t">Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Clinical features of patients with Kawasaki disease whose parents had the same disease. Arch Pediatr Adolesc Med 2004; 158:1166.</a></li><li><a class="nounderline abstract_t">Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki disease in families. Pediatrics 1989; 84:666.</a></li><li><a class="nounderline abstract_t">Yeung RS. Kawasaki disease: update on pathogenesis. Curr Opin Rheumatol 2010; 22:551.</a></li><li><a class="nounderline abstract_t">McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 2017; 135:e927.</a></li><li><a class="nounderline abstract_t">Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008; 40:35.</a></li><li><a class="nounderline abstract_t">Kuo HC, Yang KD, Juo SH, et al. ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS One 2011; 6:e17370.</a></li><li><a class="nounderline abstract_t">Breunis WB, Biezeveld MH, Geissler J, et al. Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum 2006; 54:1588.</a></li><li><a class="nounderline abstract_t">Burgner D, Davila S, Breunis WB, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 2009; 5:e1000319.</a></li><li><a class="nounderline abstract_t">Breunis WB, Davila S, Shimizu C, et al. Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins. Arthritis Rheum 2012; 64:306.</a></li><li><a class="nounderline abstract_t">Burns JC, Shimizu C, Gonzalez E, et al. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis 2005; 192:344.</a></li><li><a class="nounderline abstract_t">Khor CC, Davila S, Shimizu C, et al. Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J Med Genet 2011; 48:467.</a></li><li><a class="nounderline abstract_t">Tsai FJ, Lee YC, Chang JS, et al. Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study. PLoS One 2011; 6:e16853.</a></li><li><a class="nounderline abstract_t">Kim JJ, Hong YM, Sohn S, et al. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum Genet 2011; 129:487.</a></li><li><a class="nounderline abstract_t">Khor CC, Davila S, Breunis WB, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 2011; 43:1241.</a></li><li><a class="nounderline abstract_t">Onouchi Y, Ozaki K, Burns JC, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 2012; 44:517.</a></li><li><a class="nounderline abstract_t">Lee YC, Kuo HC, Chang JS, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet 2012; 44:522.</a></li><li><a class="nounderline abstract_t">Mutter J, Yeter D. Kawasaki's disease, acrodynia, and mercury. Curr Med Chem 2008; 15:3000.</a></li><li><a class="nounderline abstract_t">Woon PY, Chang WC, Liang CC, et al. Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan. Evid Based Complement Alternat Med 2013; 2013:605123.</a></li><li><a class="nounderline abstract_t">Rodó X, Ballester J, Cayan D, et al. Association of Kawasaki disease with tropospheric wind patterns. Sci Rep 2011; 1:152.</a></li><li><a class="nounderline abstract_t">Hwang HH, Lim IS, Choi BS, Yi DY. Analysis of seasonal tendencies in pediatric Henoch-Schönlein purpura and comparison with outbreak of infectious diseases. Medicine (Baltimore) 2018; 97:e12217.</a></li><li><a class="nounderline abstract_t">Manlhiot C, Mueller B, O'Shea S, et al. Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution. PLoS One 2018; 13:e0191087.</a></li></ol></div><div id="topicVersionRevision">Topic 6416 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30952405" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Epidemiology of the Vasculitides.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12949272" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Kawasaki syndrome hospitalizations in the United States, 1997 and 2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19564276" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27817879" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Postnatal Risk of Acquiring Kawasaki Disease: A Nationwide Birth Cohort Database Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21691035" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Kawasaki disease in Mongolia: results from 2 nationwide retrospective surveys, 1996-2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21572825" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Kawasaki disease in ghana: case reports from Korle Bu teaching hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6062087" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20530917" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19237439" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17468660" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20104198" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19145710" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21343843" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Kawasaki disease in Israel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9832593" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17468651" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Kawasaki syndrome in Denmark.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7700743" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1920972" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Acute febrile mucocutaneous lymph node syndrome (Kawasaki disease) in adults: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10931420" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Kawasaki disease in older children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21628347" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Characteristics of Kawasaki disease in older children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20453601" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Kawasaki disease in adults: report of 10 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11227331" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12856980" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Kawasaki disease in parents and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16143748" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Familial occurrence of Kawasaki syndrome in North America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21447126" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pathogenesis of Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15936970" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Kawasaki disease: what is the epidemiology telling us about the etiology?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7910278" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Active or recent parvovirus B19 infection in children with Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6140493" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Variant strain of Propionibacterium acnes: a clue to the aetiology of Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17850342" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Detection of human bocavirus in children with Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7446109" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17428368" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The role of pathology in the diagnosis of systemic vasculitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1785339" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Kawasaki disease. With particular emphasis on arterial lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18067656" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Gene-expression patterns reveal underlying biological processes in Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11528596" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11145718" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Oligoclonal IgA response in the vascular wall in acute Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16235174" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18270572" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3881741" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Circulating immune complexes in Kawasaki syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9550392" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : IgA plasma cells in vascular tissue of patients with Kawasaki syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15703537" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Seasonality and temporal clustering of Kawasaki syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3198940" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20684796" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19122923" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Campylobacter enteritis in children in northern Taiwan--a 7-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19863777" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Why are women predisposed to autoimmune rheumatic diseases?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18852687" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Spatial and temporal clustering of Kawasaki syndrome cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16322132" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Infections and Kawasaki disease: implications for coronary artery outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21402552" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32386565" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Hyperinflammatory shock in children during COVID-19 pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32410760" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15583102" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Clinical features of patients with Kawasaki disease whose parents had the same disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2780128" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Kawasaki disease in families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20616737" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Kawasaki disease: update on pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28356445" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18084290" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21533171" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16645995" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Vascular endothelial growth factor gene haplotypes in Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19132087" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21905000" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15962231" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21571869" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21326860" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21221998" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22081228" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22446962" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A genome-wide association study identifies three new risk loci for Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22446961" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19075648" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Kawasaki's disease, acrodynia, and mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24069052" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22355668" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Association of Kawasaki disease with tropospheric wind patterns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30200139" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Analysis of seasonal tendencies in pediatric Henoch-Schönlein purpura and comparison with outbreak of infectious diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29415012" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
